報價延遲最少15分鐘:2026/04/29 02:20 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
7.35 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.86/--
|
|
企業價值
211.75M
|
| 資產負債 |
|
每股賬面淨值
7.06
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
348.67M
|
|
每股收益
12.83
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products. |
